In terms of bone tissue turnover, the inhibition of aSMase by imipramine ameliorated the synergy between metabolic syndrome and Aggregatibacter actinomycetemcomitans-induced periodontitis and alveolar bone loss in a high-fat diet-fed murine model [211]. The gene discussed is SMPD1; the disease is metabolic syndrome.